Swiss Tropical and Public Health Institute

FORE Awards $2 Million in New Grants to Improve Access to Medications for Opioid Use Disorder in Pharmacies and Emergency Departments

Retrieved on: 
Wednesday, March 8, 2023
United States drug overdose death rates and totals over time, Howard University Hospital, University of Kentucky College of Pharmacy, Pharmacist, Drug, Opioid use disorder, Massachusetts General Hospital, Swiss Tropical and Public Health Institute, University, Howard University, Fellow of the American College of Emergency Physicians, MPH, National Association, Patient, National Association of Boards of Pharmacy, School, Naloxone, Organization, Prescription, American College, Stigma, Houston Community College, Emergency medicine, Emergency, Buprenorphine, Nursing, Pharmaceutical industry, MD, Pharmacy

Since its founding in 2018, FORE has awarded grants totaling $33.9 million to address the national crisis.

Key Points: 
  • Since its founding in 2018, FORE has awarded grants totaling $33.9 million to address the national crisis.
  • “Pharmacies and emergency departments have a vital role in ensuring that patients receive the medications they need in a timely manner.
  • Black residents of lower-income areas of Washington, DC, are disproportionately affected by opioid use disorder and overdose deaths yet have limited access to medications for opioid use disorder in their communities.
  • This latest grant continues FORE’s work to accelerate the ability of the nation’s emergency departments to fight the opioid crisis.

The European Medicines Agency (EMA) Validated Regulatory Application for Arpraziquantel, a Potential Treatment for Schistosomiasis in Preschool-Aged Children

Retrieved on: 
Monday, January 23, 2023
UNDP, Snail, Human, European Medicines Agency, Health, Tropics, Partnership, Institute for Colored Youth, SCI, PPP, Kenya Medical Research Institute, Disease, Government of Japan, Swiss Tropical and Public Health Institute, Schistosoma mansoni, Death, Parasitism, Schistosoma haematobium, SCI Foundation, Volunteering, Water, Ministry, Vaccine, Anemia, Consortium, Research, Malaria, Global Health Innovative Technology Fund, Taste, EMA, Learning, Drinking water, Skin, Tuberculosis, Praziquantel, Tropical disease, Bill & Melinda Gates Foundation, Bill, United Nations Development Programme, Child, Tropical climate, United Nations, Pharmaceutical industry, Birth control, Merck, Wellcome, Schistosomiasis

Arpraziquantel, developed by the Pediatric Praziquantel Consortium, is a potential new treatment option tailored to improve child health by filling the treatment gap of an estimated 50 million preschool-aged children with schistosomiasis.

Key Points: 
  • Arpraziquantel, developed by the Pediatric Praziquantel Consortium, is a potential new treatment option tailored to improve child health by filling the treatment gap of an estimated 50 million preschool-aged children with schistosomiasis.
  • On behalf of the Pediatric Praziquantel Consortium, Merck submitted the regulatory application for arpraziquantel to the European Medicines Agency (EMA), which validated this application and started the scientific review process in December 2022.
  • Arpraziquantel represents the first investigational drug that has reached the regulatory phase amongst the portfolio of projects supported by GHIT Fund.
  • The drug praziquantel – the current standard treatment developed in the 1970s – is safe, effective and available for school-aged children and adults.

Foundation for Opioid Response Efforts Announces New Grants to Expand Access to Treatment for Opioid Use Disorder in Emergency Departments and Public Mental Health Clinics

Retrieved on: 
Wednesday, December 7, 2022
Massachusetts General Hospital, Opioid use disorder, American College, Public policy, Hospital, Swiss Tropical and Public Health Institute, RAND, Corporation, RAND Corporation, Emergency, Health care, Environment, National Association Medical Staff Services, Patient, Pharmaceutical industry, Medicine

New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced new funding to increase access to treatment for opioid use disorder, including medications and peer supports, in hospital emergency departments and public mental health clinics nationwide.

Key Points: 
  • New York, Dec. 07, 2022 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced new funding to increase access to treatment for opioid use disorder, including medications and peer supports, in hospital emergency departments and public mental health clinics nationwide.
  • California Bridge (CA Bridge) will receive $500,000 over two years to continue expanding access to life-saving medications for opioid use disorder in emergency departments in every state.
  • Yet less than 10 percent of emergency departments in the United States offer medications for opioid use disorder.
  • “Emergency departments and public mental health clinics can serve as critical access points for connecting patients with opioid use disorder treatment, particularly those at high risk or with complex needs.” says Dr. Karen A. Scott, president of the Foundation for Opioid Response Efforts.

Socially Determined Partners with Institute for Public Health Innovation to Strengthen Health Care Access and Advance Health Equity Across Virginia

Retrieved on: 
Thursday, April 28, 2022
Technology, Philanthropy, Software, Other Health, Internet, Health, General Health, Foundation, Data Management, Solution, Social determinants of health in poverty, Economy, Risk management, Program, LinkedIn, CHW, Institute, Temporary Emergency Food Assistance Program, Twitter, Coronavirus, Housing, Investment, Social determinants of health, Economic security, Policy, Health, COVID-19, Organization, Partnership, United States Public Health Service, Virginia Department of Behavioral Health and Developmental Services, History, West Virginia Department of Health and Human Resources, National Network, DC, Independent Healthcare Providers Network, CDC, Facebook, Ethics, Risk, District, Environment, Center, Korea Disease Control and Prevention Agency, Trust, Swiss Tropical and Public Health Institute, Renewable energy

Socially Determined and the Institute for Public Health Innovation (IPHI) today announced an innovative partnership to enhance healthcare access and address disparities across Virginia.

Key Points: 
  • Socially Determined and the Institute for Public Health Innovation (IPHI) today announced an innovative partnership to enhance healthcare access and address disparities across Virginia.
  • CHWs for a Healthy VA is a collaborative effort led by IPHI on behalf of the Virginia Department of Health.
  • Were grateful to partner with them on this important work to advance our shared goal of improving access and equity.
  • Institute for Public Health Innovation IPHI develops multi-sector partnerships and innovative solutions to improve the publics health and well-being across Maryland, Virginia, and the District of Columbia.

NCOA Joins National Initiative to Promote COVID Vaccination

Retrieved on: 
Thursday, August 19, 2021
COVID, NCOA, Human services, Social media, Health, Awareness, National Council, National Association, Color, Medicine, Hawai, Democracy, Swiss Tropical and Public Health Institute, Migrant Clinicians Network, Supplemental Nutrition Assistance Program, Food, CEO, Vaccination, RISE, National Council on Aging, Center, Medicare, World, Community, Meal, Office of Inspector General, U.S. Department of Health and Human Services, Education, Senior, SNAP, Income, View, Human, Gaps, Multimedia, Center for Popular Democracy, Animal, Health insurance, Vaccine

The COVID pandemic has revealed and worsened persistent racial, ethnic, and socioeconomic health inequities, with vastly different rates of COVID cases, vaccination rates, and health and life outcomes in communities of color.

Key Points: 
  • The COVID pandemic has revealed and worsened persistent racial, ethnic, and socioeconomic health inequities, with vastly different rates of COVID cases, vaccination rates, and health and life outcomes in communities of color.
  • The Communities RISE Together initiative aims to address these gaps through local messengers who are already on the ground and have deep trust in communities.
  • Over the six-month project, NCOA will work across 12 states in 35 counties for targeted vaccination outreach, education, and awareness.
  • The National Council on Aging (NCOA) is the national voice for every person's right to age well.

Scientists from Merck and the Walter and Eliza Hall Institute of Medical Research Discover Novel Class of Candidate Anti Malaria Agents that Block Multiple Stages of the Lifecycle of the Parasite

Retrieved on: 
Wednesday, March 4, 2020
Health, Other Science, General Health, Research, Science, Pharmaceutical, Biotechnology, Infectious diseases, Medical specialties, Medicine, RTT, Malaria, Vaccine, Plasmodium falciparum, Swiss Tropical and Public Health Institute, Protease inhibitor, Malaria, the Walter and Eliza Hall Institute of Medical Research, Merck

We are excited about the potential of novel dual inhibitors of PMIX and PMX as potential drugs for the treatment and prevention of malaria infection.

Key Points: 
  • We are excited about the potential of novel dual inhibitors of PMIX and PMX as potential drugs for the treatment and prevention of malaria infection.
  • In this preclinical research, scientists from Merck and the Walter and Eliza Hall Institute of Medical Research and the Swiss Tropical and Public Health Institute in Basel, screened a targeted library of protease inhibitors that kill the P. falciparum parasite.
  • For more than 80 years, Merck has contributed to the discovery and development of novel medicines and vaccines to combat infectious diseases.
  • The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.